IBDEI0LV ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10196,0)
 ;;=G51.0^^44^502^4
 ;;^UTILITY(U,$J,358.3,10196,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10196,1,3,0)
 ;;=3^Bell's Palsy
 ;;^UTILITY(U,$J,358.3,10196,1,4,0)
 ;;=4^G51.0
 ;;^UTILITY(U,$J,358.3,10196,2)
 ;;=^13238
 ;;^UTILITY(U,$J,358.3,10197,0)
 ;;=G51.3^^44^502^10
 ;;^UTILITY(U,$J,358.3,10197,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10197,1,3,0)
 ;;=3^Clonic Hemifacial Spasm
 ;;^UTILITY(U,$J,358.3,10197,1,4,0)
 ;;=4^G51.3
 ;;^UTILITY(U,$J,358.3,10197,2)
 ;;=^5003995
 ;;^UTILITY(U,$J,358.3,10198,0)
 ;;=G51.4^^44^502^16
 ;;^UTILITY(U,$J,358.3,10198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10198,1,3,0)
 ;;=3^Facial Myokymia
 ;;^UTILITY(U,$J,358.3,10198,1,4,0)
 ;;=4^G51.4
 ;;^UTILITY(U,$J,358.3,10198,2)
 ;;=^5003996
 ;;^UTILITY(U,$J,358.3,10199,0)
 ;;=G51.8^^44^502^17
 ;;^UTILITY(U,$J,358.3,10199,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10199,1,3,0)
 ;;=3^Facial Nerve Disorders NEC
 ;;^UTILITY(U,$J,358.3,10199,1,4,0)
 ;;=4^G51.8
 ;;^UTILITY(U,$J,358.3,10199,2)
 ;;=^5003997
 ;;^UTILITY(U,$J,358.3,10200,0)
 ;;=H34.01^^44^502^53
 ;;^UTILITY(U,$J,358.3,10200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10200,1,3,0)
 ;;=3^Transient Retinal Artery Occlusion,Right Eye
 ;;^UTILITY(U,$J,358.3,10200,1,4,0)
 ;;=4^H34.01
 ;;^UTILITY(U,$J,358.3,10200,2)
 ;;=^5005553
 ;;^UTILITY(U,$J,358.3,10201,0)
 ;;=H34.02^^44^502^52
 ;;^UTILITY(U,$J,358.3,10201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10201,1,3,0)
 ;;=3^Transient Retinal Artery Occlusion,Left Eye
 ;;^UTILITY(U,$J,358.3,10201,1,4,0)
 ;;=4^H34.02
 ;;^UTILITY(U,$J,358.3,10201,2)
 ;;=^5005554
 ;;^UTILITY(U,$J,358.3,10202,0)
 ;;=G45.3^^44^502^3
 ;;^UTILITY(U,$J,358.3,10202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10202,1,3,0)
 ;;=3^Amaurosis Fugax
 ;;^UTILITY(U,$J,358.3,10202,1,4,0)
 ;;=4^G45.3
 ;;^UTILITY(U,$J,358.3,10202,2)
 ;;=^304129
 ;;^UTILITY(U,$J,358.3,10203,0)
 ;;=H53.2^^44^502^12
 ;;^UTILITY(U,$J,358.3,10203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10203,1,3,0)
 ;;=3^Diplopia
 ;;^UTILITY(U,$J,358.3,10203,1,4,0)
 ;;=4^H53.2
 ;;^UTILITY(U,$J,358.3,10203,2)
 ;;=^35208
 ;;^UTILITY(U,$J,358.3,10204,0)
 ;;=H47.11^^44^502^37
 ;;^UTILITY(U,$J,358.3,10204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10204,1,3,0)
 ;;=3^Papilledema Associated w/ Increased Intracranial Pressure
 ;;^UTILITY(U,$J,358.3,10204,1,4,0)
 ;;=4^H47.11
 ;;^UTILITY(U,$J,358.3,10204,2)
 ;;=^269212
 ;;^UTILITY(U,$J,358.3,10205,0)
 ;;=H47.20^^44^502^35
 ;;^UTILITY(U,$J,358.3,10205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10205,1,3,0)
 ;;=3^Optic Atrophy,Unspec
 ;;^UTILITY(U,$J,358.3,10205,1,4,0)
 ;;=4^H47.20
 ;;^UTILITY(U,$J,358.3,10205,2)
 ;;=^5006126
 ;;^UTILITY(U,$J,358.3,10206,0)
 ;;=H47.321^^44^502^15
 ;;^UTILITY(U,$J,358.3,10206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10206,1,3,0)
 ;;=3^Drusen of Optic Disc,Right Eye
 ;;^UTILITY(U,$J,358.3,10206,1,4,0)
 ;;=4^H47.321
 ;;^UTILITY(U,$J,358.3,10206,2)
 ;;=^5006141
 ;;^UTILITY(U,$J,358.3,10207,0)
 ;;=H47.322^^44^502^14
 ;;^UTILITY(U,$J,358.3,10207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10207,1,3,0)
 ;;=3^Drusen of Optic Disc,Left Eye
 ;;^UTILITY(U,$J,358.3,10207,1,4,0)
 ;;=4^H47.322
 ;;^UTILITY(U,$J,358.3,10207,2)
 ;;=^5006142
 ;;^UTILITY(U,$J,358.3,10208,0)
 ;;=H47.323^^44^502^13
 ;;^UTILITY(U,$J,358.3,10208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10208,1,3,0)
 ;;=3^Drusen of Optic Disc,Bilateral
 ;;^UTILITY(U,$J,358.3,10208,1,4,0)
 ;;=4^H47.323
 ;;^UTILITY(U,$J,358.3,10208,2)
 ;;=^5006143
 ;;^UTILITY(U,$J,358.3,10209,0)
 ;;=H47.331^^44^502^43
 ;;^UTILITY(U,$J,358.3,10209,1,0)
 ;;=^358.31IA^4^2
